MediPharm Labs (TSE:LABS) has released an update.
MediPharm Labs Corp., a pharmaceutical company specializing in cannabis-based health products, has announced the repayment of its entire convertible debt of $2.1 million, achieving a materially debt-free status. The company now boasts a strong financial standing with over $13 million in cash reserves and a near breakeven adjusted EBITDA, positioning it confidently for future growth and investment in its operations.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
